Annual Drug Patent Expirations for UBRELVY
Ubrelvy is a drug marketed by Abbvie and is included in one NDA. It is available from one supplier. There are seven patents protecting this drug.
Drug patent litigation for UBRELVY.
This drug has ninety-three patent family members in forty-five countries.
The generic ingredient in UBRELVY is ubrogepant. One supplier is listed for this compound. Additional details are available on the ubrogepant profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
